Speaker illustration

Doctor Lothar Roessig

Research Triangle Park (United States of America)

Member of:

European Society of Cardiology

Gene Therapy For Heart Failure

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Topic: Drugs, Drug Targets

Session: Industry perspective in basic and translational heart failure

Thumbnail

Safety and efficacy of a phase 1 clinical gene therapy trial in patients with advanced heart failure using a rationally designed cardiotropic AAV vector targeting protein phosphatase inhibitor-1

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 5

Thumbnail

ESC 365 is supported by